𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer

✍ Scribed by Gumersindo Pérez Manga; Parham Khosravi Shahi; Miguel Méndez Ureña; Rosa Quiben Pereira; María Isabel Palomero Plaza; Yann Izarzugaza Peron; Ricardo González Del Val; Joaquín Belón Carrión; Esperanza Pérez Cañón; Pilar García Alfonso

Publisher
Springer Japan
Year
2009
Tongue
English
Weight
214 KB
Volume
17
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel plus epidoxorubicin as neoadju
Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study
✍ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##